SCHEMBL22182115

SCHEMBL22182115

NNc1ccc(-c2ccc(NCCCN3C(=O)c4cccc5cccc(c45)C3=O)cc2)cc1N

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SIRT1 Q96EB6 3/20 0.49
▸ HEXA P06865 7/20 0.47
▸ HEXB P07686 7/20 0.47
▸ OGA O60502 1/20 0.45
▸ HDAC3 O15379 2/20 0.45
▸ HDAC4 P56524 2/20 0.45
▸ HDAC1 Q13547 2/20 0.45
▸ HDAC7 Q8WUI4 2/20 0.45
▸ HDAC2 Q92769 2/20 0.45
▸ HDAC10 Q969S8 2/20 0.45
▸ HDAC11 Q96DB2 2/20 0.45
▸ HDAC8 Q9BY41 2/20 0.45
▸ HDAC6 Q9UBN7 2/20 0.45
▸ HDAC9 Q9UKV0 2/20 0.45
▸ HDAC5 Q9UQL6 2/20 0.45
▸ NCOR2 Q9Y618 2/20 0.45
▸ MEN1 O00255 3/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ LTA4H P09960 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22181861 0.89 SIRT1 (0.53) SIRT1HEXAHEXBOGAHDAC3
SCHEMBL22181902 0.87 SIRT1 (0.57) SIRT1HEXAHEXBOGAHDAC3
SCHEMBL22181894 0.85 SIRT1 (0.53) SIRT1HEXAHEXBOGAHDAC3
SCHEMBL22181988 0.85 SIRT1 (0.53) SIRT1HEXAHEXBOGAHDAC3
SCHEMBL22181854 0.85 SIRT1 (0.57) SIRT1HEXAHEXBOGAHDAC3
SCHEMBL22182117 0.84 SIRT1 (0.50) SIRT1HEXAHEXBOGAHDAC3
SCHEMBL22181892 0.83 SIRT1 (0.51) SIRT1HEXAHEXBOGAHDAC3
SCHEMBL22181859 0.82 HEXA (0.63) SIRT1HEXAHEXBOGAHDAC3
SCHEMBL22181986 0.82 SIRT1 (0.47) SIRT1HEXAHEXBOGAHDAC3
SCHEMBL22182084 0.82 SIRT1 (0.47) SIRT1HEXAHEXBOGAHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020139291-A1 NAPHTHALIMIDE DERIVATIVES AS ANTI-PARASITIC AGENTS FOR THE TREATMENT OF LEISHMANIASIS AS WELL AS VIRAL, BACTERIAL AND NEOPLASTIC DISEASES ISTANBUL MEDIPOL UNIVERSITESI (TR) 2020-07-02 — — WO disclosed
Send feedback